Ofloxacin tablets (CAS 128074-72-6) — formula C17H21ClFN3O4, molecular weight 385.8; category specialty chemicals.
Ofloxacin tablets (CAS 128074-72-6) is a chemical raw material in the specialty chemicals category. Its molecular formula C17H21ClFN3O4 comprises 17 C, 21 H, 1 Cl, 1 F, 3 N, 4 O atoms. Its molecular weight is about 385.8. As a sourcing and distribution partner we help locate and compare this item across domestic and cross-border channels, arranging samples and batch orders with full COA and compliance files.
| CAS Number | 128074-72-6 |
|---|---|
| Molecular Formula | C17H21ClFN3O4 |
| Molecular Weight | 385.8 |
| Applications | For the treatment of the following infections caused by susceptible organisms: urinary tract infections, acute uncomplicated cystitis, chronic bacterial prostatitis, lower respiratory tract infections, acute sinusitis, skin and skin structure infections |
| Category | Specialty Chemicals |
Documented applications: For the treatment of the following infections caused by susceptible organisms: urinary tract infections, acute uncomplicated cystitis, chronic bacterial prostatitis, lower respiratory tract infections, acute sinusitis, skin and skin structure infections.
Ofloxacin tablets is a specialty compound with CAS registry number 128074-72-6 and molecular formula C17H21ClFN3O4 (molecular weight 385.8), belonging to the specialty chemicals segment of chemical raw materials.
CAS number: 128074-72-6
Its molecular formula C17H21ClFN3O4 comprises 17 C, 21 H, 1 Cl, 1 F, 3 N, 4 O atoms.
Also known as: Ofloxacin tablets · CiprofloxacinHCL
Category: specialty chemicals
The CAS registry number of Ofloxacin tablets is 128074-72-6.
Molecular formula C17H21ClFN3O4, molecular weight 385.8.
It is also registered under: Ofloxacin tablets, CiprofloxacinHCL.
Recorded applications: For the treatment of the following infections caused by susceptible organisms: urinary tract infections, acute uncomplicated cystitis, chronic bacterial prostatitis, lower respiratory tract infections, acute sinusitis, skin and skin structure infections.
Category: Specialty Chemicals.
Packaging is agreed per order, from lab-scale packs to bulk, and confirmed with each order rather than fixed on the page. A Certificate of Analysis (COA) ships with every batch and MSDS is available; where the end use carries a regulatory limit (food contact, pharmaceutical or cosmetic), state the standard at enquiry and the grade is set against it.
Independent reference data for Ofloxacin tablets (CAS 128074-72-6), compiled from public chemistry databases.
| CAS Registry Number | 128074-72-6 |
|---|---|
| PubChem CID | 62998 |
| Molecular formula | C17H21ClFN3O4 |
| IUPAC name | 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;hydrate;hydrochloride |
| UNII (FDA) | 4BA73M5E37 |
| Molecular Weight | 385.8 |
|---|---|
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 3 |
| Exact Mass | 385.1204620 |
| Monoisotopic Mass | 385.1204620 |
| Topological Polar Surface Area | 73.9 |
| Heavy Atom Count | 26 |
86393-32-0; Ciprofloxacin hydrochloride monohydrate; Ciloxan; Ciprofloxacin hydrochloride hydrate; Ciprofloxacin HCl; Cipropol; Flociprin; Proquin XR; Bay o 9867 monohydrate; Proquin; Ciflox; Bay-o-9867 monohydrate; Cetraxal; 4BA73M5E37; ciprofloxacin monohydrochloride monohydrate; Ciprofloxacin (as hydrochloride)
| GHS notification summary | 15.8% (28 / 177) |
|---|
| GHS notification summary | 15.8% (28 / 177) |
|---|---|
| Reported hazard statements | H319 (82.5%), H412 (71.8%) |
This chemical does not meet GHS hazard criteria for 15.8% (28 of 177) of reports.
H319 (82.5%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
Ofloxacin tablets · CAS 128074-72-6 · C17H21ClFN3O4. UNII 4BA73M5E37.
Source: PubChem / Wikidata; the batch COA governs where values differ.
Supplier: Jinan Shenghe Chemical Co., Ltd.
中文页面: Ofloxacin tablets